• Twinkle Bansode
  • Amit Gupta Vidya Pratishthan School of Biotechnology
  • Bharat Shinde
  • Salalkar Bk


Introduction: Evaluation of antidiabetic studies was conducted on different medicinal plant products (Trigonella foenum-graecum, seeds; Syzygium
cumini, seeds; Salavadora persica, leaves; and Terminalia chebula, seeds) on human whole blood samples. Since centuries revealed the presence of
potent antidiabetic activity in primary and secondary metabolites of medicinal plant products.
Objective: The objective of our study is to screen these plant extracts of four different medicinal plant products on diabetic human whole blood samples.
Methods: In this study, we screened plant extracts pertaining to determine its secondary metabolites qualitatively and also analyzed its activity on
diabetic human whole blood samples to determine total cellular content, free hemoglobin in the supernatant and also estimated its glucose content.
Results: The results of these studies claimed that these plant extracts showed antidiabetic effect at lower doses because of decline in total cellular
content, free hemoglobin in the supernatant, and glucose content. Overall, this study claimed that all these plant extracts showed antidiabetic activity.
Conclusion: Overall, this study claimed that all these plant extracts showed antidiabetic activity.
Keywords: Trigonella foenum-graecum, Syzygium cumini, Salavadora persica, Terminalia chebula, Antidiabetic.



Gupta M, Singh R, Lehl SS. Diabetes in India: A long way to go. Int J

Sci Rep 2015;1(1):1-2.

Baruah MP, Pathak A, Kalra S, Das AK, Zargar AH, Bajaj S, et al.

A revisit to prevailing care and challenges of managing diabetes

in India: Focus on regional disparities. Indian J Endocrinol Metab


Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on

antidiabetic medicinal plants having insulin mimetic property. Asian

Pac J Trop Biomed 2012;2(4):320-30.

Deutschländer MS, van de Venter M, Roux S, Louw J, Lall N.

Hypoglycaemic activity of four plant extracts traditionally used in

South Africa for diabetes. J Ethnopharmacol 2009;124(3):619-24.

Kumari L, Mazumder PM. HPTLC finger printing profile and

evaluation of in-vitro antioxidant activity of extracts from seeds of

Trigonella foneum graecum Linn in different solvents. Int J Res Pharm

Biomed Sci 2013;4(2):417-27.

Subhashini N, Thangathirupathi A, Lavanya N. Antioxidant activity of

Trigonella foenum graecum using various in vitro and ex vivo models.

Int J Pharm pharm Sci 2011;3(2):96-102.

Bansode TS, Gupta A, Chaphalkar SR, Salalkar BK. Integrating in-silico

and in-vitro approaches to screen the antidiabetic drug from Trigonella

foenum graecum Linn. Int J Biochem Res Rev 2016;14(3):1-10.

Sreeja S, Anju VS, Sreeja S. In vitro estrogenic activities of fenugreek

Trigonella foenum graecum seeds. Indian J Med Res 2010;131:814-9.

Gupta A, Chaphalkar SR. Flow cytometry based assay of formulation

from Syzygium cumini in human whole blood and glycosylated red

blood cells. J Pharm Res 2014;3(12):265-70.

Prince P, Venon M. Effect of Syzigium cumini in plasma antioxidants

Innovare Journal of Health Sciences, Vol 5, Issue 2, 2017, 1-4

Bansode et al.

on alloxan-induced diabetes in rats. J Clin Biochem Nutr


Bansode TS, Gupta A, Salalkar BK. In silico and in vitro assessment

on antidiabetic efficacy of secondary metabolites from Syzygium

cumini (L.) Skeels. Plant Sci Today 2016;3(4):360-7.

Sukkarwalla A, Ali SM, Lundberg P, Tanwir F. Efficacy of miswak on

oral pathogens. Dent Res J 2013;10(3):314-20.

Bansode TS, Salalkar BK. Exploiting the therapeutic potential of

secondary metabolites from Salvadora persica for diabetes using

in silico and in vitro approach. J Life Sci Biotechnol 2016;5:127-36.

Bag A, Bhattacharyya SK, Chattopadhyay RR. The development of

Terminalia chebula Retz. (Combretaceae) in clinical research. Asian

Pac J Trop Biomed 2013;3(3):244-52.

Tamhane MD, Thorat SP, Rege NN, Dahanukar SA. Effect of oral

administration of Terminalia chebula on gastric emptying: An

experimental study. J Postgrad Med 1997;43(1):12-3.

Afshari AR, Sadeghnia HR, Mollazadeh H. A review on potential

mechanisms of Terminalia chebula in Alzheimer’s disease. Adv

Pharmacol Sci 2016;2016:8964849.

Belapurkar P, Goyal P, Tiwari-Barua P. Immunomodulatory effects of

triphala and its individual constituents: A review. Indian J Pharm Sci


Kumar A. A review of traditional anticancer nano-medicine: Triphala.

Pharm Innov J 2014;3(7):60-6.

Gupta R, Gupta A, Singh RL. Hepatoprotective activities of Triphala

and its constituents. Int J Pharm Res Rev 2015;4:34-55.

Shaikh AC, Gupta A, Chaphalkar SR. Quantitative phytochemical

credential of Nakshtra plants and distribution analysis of aldehydes

pertaining to LC-MS. Int J Chem Pharm Sci 2016;4(8):408-15.

Gupta A, Chaphalkar SR. Haemolytic activities and anti-diabetic effect

of Terminalia arjuna and Emblica officinalis. Eur J Pharm Med Res


Singab AN, Youssef FS, Ashour ML. Medicinal plants with potential

antidiabetic activity and their assessment. Med Aromatic Plants


Mamun-or-Rashid AN, Hossain MS, Hassan BN, Dash MK,

Sapon A, Sen MK. A review on medicinal plants with antidiabetic

activity. J Pharmacogn Phytochem 2014;3(4):149-59.

Hassan Z, Yam MF, Ahmad M, Yusof AP. Antidiabetic properties

and mechanism of action of Gynura procumbens water extract in

streptozotocin-induced diabetic rats. Molecules 2010;15(12):9008-23.

Eid HM, Haddad PS. Mechanisms of action of indigenous antidiabetic

plants from the boreal forest of Northeastern Canada. Adv



How to Cite

Bansode, T., Gupta, A., Shinde, B., & Bk, S. (2017). ASSESSMENT OF ANTIDIABETIC POTENTIAL OF TRADITIONAL MEDICINAL PLANTS IN HUMAN WHOLE BLOOD SAMPLES. Innovare Journal of Health Sciences, 5(2). Retrieved from



Original Article(s)